Ackman says Valeant regulatory compliance no worse than rest of pharma industry
October 30, 2015 at 15:21 PM EDT
Ackman may be setting the bar low for Valeant, based on how often drug companies pay fines for illegal activity.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.